Semaglutide CVOT, SUSTAIN-6 Visual Abstract as a GIF In fact, Novo Nordisk used data like these to gain a new indication for semaglutide just last week: Today, the [FDA] approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack, and stroke in adults with cardiovascular disease and either obesity or overweight
Conclusion GLP-1 is a weight-loss injection (slimming injection) that helps reduce the amount of food you eat
As individuals are losing fat, they are also rapidly losing precious muscle tissue
Papadopoulou-Marketou, N., Kanaka-Gantenbein, C., Marketos, N., Chrousos, G
This becomes particularly important when working with compounded semaglutide formulations where concentrations vary between pharmacies